Joshua Diamond, MD

Joshua Diamond, MD

Read through a Q&A with one of the CHEST Network leaders, Lung Transplant Section Vice-Chair, Joshua Diamond, MD.

October 30, 2023

Where do you work?
I currently am an Associate Professor at the University of Pennsylvania, and I am also the Associate Medical Director of the Penn Lung Transplant Program.

What are your research interests, and how does this apply to your position within the Networks?
I spend a significant amount of my time engaged in clinical research with two primary foci: One being primary graft dysfunction after lung transplant—what are the risk factors, how can we predict its development in order to better identify treatments, and what is the long-term impact of early allograft injury? And two being frailty in the context of lung transplantation—how can we intervene and improve the frail condition, and what are the longitudinal impacts of peritransplant frailty?

How did you become interested and involved in the Diffuse Lung Disease and Lung Transplant Network?
I started out attending the CHEST Annual Meetings and then recognized that I could really impact the field of lung transplantation through the Network by identifying needed areas of research, teaching the greater pulmonary community about some of the intricacies of lung transplant, and helping develop trainees’ interests in the world of lung transplant medicine.

Are you involved in any other activities or volunteer positions at CHEST?
I am an abstract and session proposal reviewer for the CHEST Annual Meetings.

What clinical research is most interesting to you right now?
My current research is focused on evaluating the long-term consequences of early graft injury (primary graft dysfunction [PGD]) and the impact on quality of life, development of subsequent allograft injury, as well as identifying potential therapeutic targets for PGD-directed interventions. Additionally, I am unbelievably excited about the potential for therapeutics targeting the important syndromic entities that affect patients who receive transplants, namely PGD and chronic lung allograft dysfunction.

What are your hobbies?
I enjoy road and mountain biking, skiing, hiking, kayaking, and travel—and I love to do these things with my family.

What is something you cannot live without (after family and friends)?

Is there anything else you'd like to share with your Network peers?
I am excited about the opportunity to develop the next generation of transplant clinicians, and I think CHEST is the ideal avenue for this.



Questions about this Network? Contact